266 related articles for article (PubMed ID: 16266205)
1. Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D; Keam SJ
Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on escitalopram in the management of major depressive disorder.
Murdoch D; Keam SJ
CNS Drugs; 2006; 20(2):167-70. PubMed ID: 16478291
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on the pharmacoeconomics of escitalopram in depression.
Croom KF; Plosker GL
CNS Drugs; 2004; 18(7):469-73. PubMed ID: 15139801
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
Llorca PM; Fernandez JL
Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
[TBL] [Abstract][Full Text] [Related]
9. Escitalopram: a review of its use in the management of anxiety disorders.
Dhillon S; Scott LJ; Plosker GL
CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram for the treatment of major depression and anxiety disorders.
Höschl C; Svestka J
Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.
Nordström G; Danchenko N; Despiegel N; Marteau F
Value Health; 2012; 15(2):231-9. PubMed ID: 22433753
[TBL] [Abstract][Full Text] [Related]
12. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram.
Aronson S; Delgado P
Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
[TBL] [Abstract][Full Text] [Related]
15. Bupropion: a review of its use in the management of major depressive disorder.
Dhillon S; Yang LP; Curran MP
Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram (Lexapro) for depression.
Masilamani S; Ruppelt SC
Am Fam Physician; 2003 Dec; 68(11):2235-6. PubMed ID: 14677669
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
18. Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
Kasper S; Spadone C; Verpillat P; Angst J
Int Clin Psychopharmacol; 2006 Mar; 21(2):105-10. PubMed ID: 16421462
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis.
Yin J; Song X; Wang C; Lin X; Miao M
BMC Psychiatry; 2023 Nov; 23(1):876. PubMed ID: 38001423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]